These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 3182960

  • 1. Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: efficacy of D-thyroxine therapy.
    Hamon P, Bovier-Lapierre M, Robert M, Peynaud D, Pugeat M, Orgiazzi J.
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1089-93. PubMed ID: 3182960
    [Abstract] [Full Text] [Related]

  • 2. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".
    Gershengorn MC, Weintraub BD.
    J Clin Invest; 1975 Sep; 56(3):633-42. PubMed ID: 1159077
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance.
    Kunitake JM, Hartman N, Henson LC, Lieberman J, Williams DE, Wong M, Hershman JM.
    J Clin Endocrinol Metab; 1989 Aug; 69(2):461-6. PubMed ID: 2753985
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hyperthyroidism due to familial pituitary resistance to thyroid hormone: successful control with 3, 5, 3' triiodothyroacetic associated to propranolol.
    Aguilar Diosdado M, Escobar-Jimenez L, Fernandez Soto ML, Garcia Curiel A, Escobar-Jimenez F.
    J Endocrinol Invest; 1991 Sep; 14(8):663-8. PubMed ID: 1774450
    [Abstract] [Full Text] [Related]

  • 8. Hyperthyroidism due to inappropriate TSH secretion with associated hyperprolactinaemia--a case report and review of the literature.
    Spitz IM, Sheinfeld M, Glasser B, Hirsch HJ.
    Postgrad Med J; 1984 May; 60(703):328-35. PubMed ID: 6429655
    [Abstract] [Full Text] [Related]

  • 9. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST.
    Beck-Peccoz P, Roncoroni R, Mariotti S, Medri G, Marcocci C, Brabant G, Forloni F, Pinchera A, Faglia G.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):19-25. PubMed ID: 2370293
    [Abstract] [Full Text] [Related]

  • 10. Effects of thyroid hormones (T4,T3), bromocriptine and Triac on inappropriate TSH hypersecretion.
    Salmela PI, Wide L, Juustila H, Ruokonen A.
    Clin Endocrinol (Oxf); 1988 May; 28(5):497-507. PubMed ID: 3214942
    [Abstract] [Full Text] [Related]

  • 11. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.
    Kamoi K, Mitsuma T, Sato H, Yokoyama M, Washiyama K, Tanaka R, Arai O, Takasu N, Yamada T.
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):373-82. PubMed ID: 3934894
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The spectrum of inappropriate pituitary thyrotropin secretion associated with hyperthyroidism.
    Gharib H, Carpenter PC, Scheithauer BW, Service FJ.
    Mayo Clin Proc; 1982 Sep; 57(9):556-63. PubMed ID: 7109684
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of bromocriptine administration for selective pituitary resistance to thyroid hormone.
    Ohzeki T, Hanaki K, Motozumi H, Ohtahara H, Ishitani N, Urashima H, Tsukuda T, Shiraki K, Sasaki S, Nakamura H.
    Horm Res; 1993 Sep; 39(5-6):229-34. PubMed ID: 8314208
    [Abstract] [Full Text] [Related]

  • 15. Low setting of feedback regulation of TSH secretion by thyroxine in pituitary dwarfism with TSH-releasing hormone deficiency.
    Sato T, Ishiguro K, Suzuki Y, Taketani T, Isumisawa A.
    J Clin Endocrinol Metab; 1976 Feb; 42(2):385-90. PubMed ID: 816807
    [Abstract] [Full Text] [Related]

  • 16. Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with nonthyroidal illness.
    Franklyn JA, Black EG, Betteridge J, Sheppard MC.
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1368-71. PubMed ID: 8200938
    [Abstract] [Full Text] [Related]

  • 17. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism.
    Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PW, Hershman JM.
    Arch Intern Med; 1991 Jan; 151(1):165-8. PubMed ID: 1985591
    [Abstract] [Full Text] [Related]

  • 18. [Effects of various contraceptives on laboratory parameters in diagnosis of thyroid gland function with special reference to the free hormones FT4 and FT3].
    Sorger D, Schenk S, Schneider G.
    Z Gesamte Inn Med; 1992 Feb; 47(2):58-64. PubMed ID: 1585690
    [Abstract] [Full Text] [Related]

  • 19. Familial partial target organ resistance to thyroid hormones.
    Elewaut A, Mussche M, Vermeulen A.
    J Clin Endocrinol Metab; 1976 Sep; 43(3):575-81. PubMed ID: 60346
    [Abstract] [Full Text] [Related]

  • 20. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.
    Krugman LG, Hershman JM, Chopra IJ, Levine GA, Pekary E, Geffner DL, Chua Teco GN.
    J Clin Endocrinol Metab; 1975 Jul; 41(1):70-80. PubMed ID: 807596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.